EWEdwards Lifesciences
$87.08-3.14%Real quote · delayedHeart valves🏛️ Company factsSEC filings + FINRA official data
Annual revenue $6.1B · latest quarter up 13.6% YoY · profitable (FY net income $1.1B) · short activity below its recent average — bears covering.
FY revenue
$6.1B
2025-12
Latest Q YoY
+13.6%
Gross margin
78%
FY net income
$1.1B
Diluted EPS
$1.84
Short volume
26.8%
20d avg 41.6% · shorts covering
🐋 5%+ ownership filings (last 180d)
The parties below hold over 5% of this company and disclosed it to the SEC (mandatory in US markets). "Activist" filers state an intent to influence the company; "Passive" are pure investment positions.
- 2026-04-29passive (13G)VANGUARD CAPITAL MANAGEMENT LLC
- 2026-03-26passive (13G)VANGUARD GROUP INC
🎯 Market expectations
Expectation reliability High · 83/100Nasdaq analyst consensus · the pre-news baseline
- Jun 2026$0.78 vs $0.73+6.85%
- Mar 2026$0.78 vs $0.75+4%
- Dec 2025$0.58 vs $0.62-6.45%
- Sep 2025$0.67 vs $0.59+13.56%
The takeaway
This company habitually beats by +4.5% — the next report has to clear that bar to count as good news.
Analyst estimates, not our forecast · not investment advice
🧭 -3.1% today with no fresh news · why?
- 📊 Market-0.2%S&P -0.4% × beta 0.5
- 💸 Money flowMFI 49 · net outflow · volume 0.5× average
- 🧩 PeersBSX -5.5%ISRG -4.2%SYK -7.9%MDT -1.7%PODD -3.5%DXCM -3.3%6 peers moved the same way today, averaging -4.4% — this is a sector move, not a single-stock event.
- 🕰️ Old news, still digesting▲ Stock Market Today: S&P 500, Dow Jones, Nasdaq 1structural impact active, ~14 days left
Educational decomposition · not investment advice
What's moving this stock lately
No recent news affecting this stock
🕰️ Price × news · engine report card
Drag to pan, scroll to zoom · real daily bars and volume
📜 Call history (newest first
3 engine calls on this stock — each with direction, magnitude and its verified outcome · sign up to view
Sign up · free 7-day trial →Impact chains · crowding · conviction engine · insider signals — free 7-day trial on signup.
Sign up · free 7-day trial →